IQVIA Holdings Inc. (IQV)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.43 (+0.19%)Past Day

About

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Key Insights

  • Share Price

    $227.74

  • Market Cap

    $41.52 Billion

  • Total Outstanding Shares

    182.30 Million Shares

  • Total Employees

    88,000

  • Dividend

    No dividend

  • IPO Date

    May 9, 2013

  • SIC Description

    Services-commercial Physical & Biological Research

  • Homepage

    https://www.iqvia.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2023 to June 30, 2024
MetricValue
Net Cash Flow From Financing Activities$-930.00 Million
Net Cash Flow From Operating Activities$2.44 Billion
Net Cash Flow$163.00 Million
Net Cash Flow From Financing Activities, Continuing$-930.00 Million
Net Cash Flow From Investing Activities$-1.32 Billion
Net Cash Flow, Continuing$190.00 Million
Exchange Gains/Losses$-27.00 Million
Net Cash Flow From Investing Activities, Continuing$-1.32 Billion
Net Cash Flow From Operating Activities, Continuing$2.44 Billion

Income Statement

July 1, 2023 to June 30, 2024
MetricValue
Income/Loss From Continuing Operations After Tax$1.41 Billion
Income/Loss Before Equity Method Investments$1.50 Billion
Operating Income/Loss$2.01 Billion
Income/Loss From Equity Method Investments$-2.00 Million
Income Tax Expense/Benefit, Deferred$-279.00 Million
Income Tax Expense/Benefit$73.00 Million
Benefits Costs and Expenses$13.66 Billion
Net Income/Loss$1.41 Billion
Revenues$15.15 Billion
Operating Expenses$13.01 Billion
Basic Average Shares$364.30 Million
Net Income/Loss Attributable To Parent$1.42 Billion
Costs And Expenses$13.66 Billion
Diluted Earnings Per Share$7.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Interest Expense, Operating$691.00 Million
Preferred Stock Dividends And Other Adjustments$0.00
Income/Loss From Continuing Operations Before Tax$1.50 Billion
Basic Earnings Per Share$7.80
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Diluted Average Shares$369.20 Million
Net Income/Loss Available To Common Stockholders, Basic$1.41 Billion
Selling, General, and Administrative Expenses$2.08 Billion

Balance Sheet

July 1, 2023 to June 30, 2024
MetricValue
Liabilities$19.68 Billion
Noncurrent Assets$20.78 Billion
Equity Attributable To Noncontrolling Interest$0.00
Equity$6.71 Billion
Intangible Assets$4.61 Billion
Equity Attributable To Parent$6.71 Billion
Assets$26.40 Billion
Fixed Assets$503.00 Million
Accounts Receivable$3.25 Billion
Other Non-current Assets$15.66 Billion
Prepaid Expenses$191.00 Million
Current Liabilities$6.62 Billion
Current Assets$5.62 Billion
Liabilities And Equity$26.40 Billion
Other Current Assets$2.18 Billion
Noncurrent Liabilities$13.06 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
News ArticlesAbout UsPrivacy Policy & Cookies Information

ⓒ2024 Financhle. All Rights Reserved.